{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T01:05:21Z","timestamp":1791939921411,"version":"4.3.4"},"reference-count":72,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.ejphar.2025.177317","type":"journal-article","created":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T07:56:54Z","timestamp":1738223814000},"page":"177317","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Safety, tolerability and pharmacokinetic profile of the low-impact ampakine CX717 in young healthy male subjects and elderly healthy male and female subjects"],"prefix":"10.1016","volume":"993","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3775-7712","authenticated-orcid":false,"given":"Daniel P.","family":"Radin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rok","family":"Cerne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jodi L.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey M.","family":"Witkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnold","family":"Lippa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2025.177317_bib1","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.biopsych.2012.05.012","article-title":"A translational approach to evaluate the efficacy and safety of the novel AMPA receptor positive allosteric modulator org 26576 in adult attention-deficit\/hyperactivity disorder","volume":"72","author":"Adler","year":"2012","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.ejphar.2025.177317_bib2","series-title":"53rd Annual Meeting of the American Academy of Child and Adolescent Psychiatry A42","article-title":"Treatment of adult ADHD with the novel Ampakine CX717","author":"Adler LA","year":"2006"},{"key":"10.1016\/j.ejphar.2025.177317_bib3","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232113527","article-title":"Alteration in the synaptic and extrasynaptic organization of AMPA receptors in the Hippocampus of P301S tau transgenic mice","volume":"23","author":"Alfaro-Ruiz","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2025.177317_bib4","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/j.bcp.2005.12.022","article-title":"A role for AMPA receptors in mood disorders","volume":"71","author":"Alt","year":"2006","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejphar.2025.177317_bib5","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/S0006-8993(98)00446-6","article-title":"The waveform of synaptic transmission at hippocampal synapses is not determined by AMPA receptor desensitization","volume":"799","author":"Arai","year":"1998","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2025.177317_bib6","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/S0026-895X(24)23113-8","article-title":"Effects of the potent ampakine CX614 on hippocampal and recombinant AMPA receptors: interactions with cyclothiazide and GYKI 52466","volume":"58","author":"Arai","year":"2000","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejphar.2025.177317_bib7","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1124\/jpet.102.040360","article-title":"Benzamide-type AMPA receptor modulators form two subfamilies with distinct modes of action","volume":"303","author":"Arai","year":"2002","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejphar.2025.177317_bib8","doi-asserted-by":"crossref","first-page":"851","DOI":"10.24272\/j.issn.2095-8137.2022.122","article-title":"Deficiency of transmembrane AMPA receptor regulatory protein gamma-8 leads to attention-deficit hyperactivity disorder-like behavior in mice","volume":"43","author":"Bai","year":"2022","journal-title":"Zool. Res."},{"key":"10.1016\/j.ejphar.2025.177317_bib9","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.schres.2020.01.025","article-title":"AMPA receptor subunit localization in schizophrenia anterior cingulate cortex","volume":"249","author":"Benesh","year":"2022","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.ejphar.2025.177317_bib10","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.biopsych.2005.09.011","article-title":"A randomized, placebo-controlled trial of OROS methylphenidate in adults with attention-deficit\/hyperactivity disorder","volume":"59","author":"Biederman","year":"2006","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.ejphar.2025.177317_bib11","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1177\/0269881111405353","article-title":"Acute sleep deprivation: the effects of the AMPAKINE compound CX717 on human cognitive performance, alertness and recovery sleep","volume":"26","author":"Boyle","year":"2012","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.ejphar.2025.177317_bib12","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0896-6273(03)00640-8","article-title":"AMPA receptor trafficking at excitatory synapses","volume":"40","author":"Bredt","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.ejphar.2025.177317_bib13","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1038\/npp.2017.30","article-title":"Disrupted glutamatergic transmission in prefrontal cortex contributes to behavioral abnormality in an animal model of ADHD","volume":"42","author":"Cheng","year":"2017","journal-title":"Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology"},{"key":"10.1016\/j.ejphar.2025.177317_bib14","doi-asserted-by":"crossref","first-page":"3766","DOI":"10.1523\/JNEUROSCI.5780-10.2011","article-title":"AMPA receptor-induced local brain-derived neurotrophic factor signaling mediates motor recovery after stroke","volume":"31","author":"Clarkson","year":"2011","journal-title":"J. Neurosci. : the official journal of the Society for Neuroscience"},{"key":"10.1016\/j.ejphar.2025.177317_bib15","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1038\/jcbfm.2015.33","article-title":"Combined ampakine and BDNF treatments enhance poststroke functional recovery in aged mice via AKT-CREB signaling","volume":"35","author":"Clarkson","year":"2015","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.ejphar.2025.177317_bib16","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3389\/fphar.2019.00105","article-title":"The impact and mechanism of a novel allosteric AMPA receptor modulator LCX001 on protection against respiratory depression in rodents","volume":"10","author":"Dai","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejphar.2025.177317_bib17","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1172\/JCI77888","article-title":"Long-term potentiation decay and memory loss are mediated by AMPAR endocytosis","volume":"125","author":"Dong","year":"2015","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ejphar.2025.177317_bib18","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.schres.2013.03.010","article-title":"Transmembrane AMPA receptor regulatory protein (TARP) dysregulation in anterior cingulate cortex in schizophrenia","volume":"147","author":"Drummond","year":"2013","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.ejphar.2025.177317_bib19","doi-asserted-by":"crossref","first-page":"3498","DOI":"10.1007\/s12035-020-01954-x","article-title":"Antidepressant-like effects of CX717, a positive allosteric modulator of AMPA receptors","volume":"57","author":"Gordillo-Salas","year":"2020","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.ejphar.2025.177317_bib20","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.resp.2009.02.011","article-title":"Ampakine therapy to counter fentanyl-induced respiratory depression","volume":"168","author":"Greer","year":"2009","journal-title":"Respir. Physiol. Neurobiol."},{"key":"10.1016\/j.ejphar.2025.177317_bib21","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s00213-008-1360-z","article-title":"Mechanisms underlying cognitive enhancement and reversal of cognitive deficits in nonhuman primates by the ampakine CX717","volume":"202","author":"Hampson","year":"2009","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.ejphar.2025.177317_bib22","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S0306-4522(03)00423-8","article-title":"Ampakines reduce methamphetamine-driven rotation and activate neocortex in a regionally selective fashion","volume":"121","author":"Hess","year":"2003","journal-title":"Neuroscience"},{"key":"10.1016\/j.ejphar.2025.177317_bib23","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.brainres.2008.01.033","article-title":"Glutamate-stimulated release of norepinephrine in hippocampal slices of animal models of attention-deficit\/hyperactivity disorder (spontaneously hypertensive rat) and depression\/anxiety-like behaviours (Wistar-Kyoto rat)","volume":"1200","author":"Howells","year":"2008","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2025.177317_bib24","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.neuropharm.2018.04.020","article-title":"AMPA receptor positive allosteric modulators attenuate morphine tolerance and dependence","volume":"137","author":"Hu","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2025.177317_bib25","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1097\/00005072-199709000-00007","article-title":"The loss of GluR2(3) immunoreactivity precedes neurofibrillary tangle formation in the entorhinal cortex and hippocampus of Alzheimer brains","volume":"56","author":"Ikonomovic","year":"1997","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.ejphar.2025.177317_bib26","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1006\/exnr.2000.7544","article-title":"Age-related loss of the AMPA receptor subunits GluR2\/3 in the human nucleus basalis of Meynert","volume":"166","author":"Ikonomovic","year":"2000","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.ejphar.2025.177317_bib27","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/S0022-3565(24)38148-0","article-title":"Synergistic interactions between ampakines and antipsychotic drugs","volume":"289","author":"Johnson","year":"1999","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejphar.2025.177317_bib28","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/310146","article-title":"Downregulated GABA and BDNF-TrkB pathway in chronic cyclothiazide seizure model","volume":"2014","author":"Kong","year":"2014","journal-title":"Neural Plast."},{"key":"10.1016\/j.ejphar.2025.177317_bib29","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.brainres.2010.07.088","article-title":"Cyclothiazide induces seizure behavior in freely moving rats","volume":"1355","author":"Kong","year":"2010","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2025.177317_bib30","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1038\/s41386-018-0213-7","article-title":"TAK-137, an AMPA-R potentiator with little agonistic effect, has a wide therapeutic window","volume":"44","author":"Kunugi","year":"2019","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ejphar.2025.177317_bib31","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0006-8993(96)01049-9","article-title":"Effects of an AMPA receptor modulator on methamphetamine-induced hyperactivity in rats","volume":"738","author":"Larson","year":"1996","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2025.177317_bib32","doi-asserted-by":"crossref","first-page":"3538","DOI":"10.1152\/jn.00287.2006","article-title":"Cyclothiazide prolongs low [Mg2+]-induced seizure-like events","volume":"96","author":"Lasztoczi","year":"2006","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.ejphar.2025.177317_bib33","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1523\/JNEUROSCI.20-01-00008.2000","article-title":"Positive modulation of AMPA receptors increases neurotrophin expression by hippocampal and cortical neurons","volume":"20","author":"Lauterborn","year":"2000","journal-title":"J. Neurosci. : the official journal of the Society for Neuroscience"},{"key":"10.1016\/j.ejphar.2025.177317_bib34","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1124\/jpet.103.053694","article-title":"Chronic elevation of brain-derived neurotrophic factor by ampakines","volume":"307","author":"Lauterborn","year":"2003","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejphar.2025.177317_bib35","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0008766","article-title":"Opiate-induced suppression of rat hypoglossal motoneuron activity and its reversal by ampakine therapy","volume":"5","author":"Lorier","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2025.177317_bib36","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.biopsych.2007.11.008","article-title":"A randomized, placebo-controlled trial of three fixed dosages of prolonged-release OROS methylphenidate in adults with attention-deficit\/hyperactivity disorder","volume":"63","author":"Medori","year":"2008","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.ejphar.2025.177317_bib37","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1124\/jpet.109.158014","article-title":"Modulation of agonist binding to AMPA receptors by 1-(1,4-benzodioxan-6-ylcarbonyl)piperidine (CX546): differential effects across brain regions and GluA1-4\/transmembrane AMPA receptor regulatory protein combinations","volume":"331","author":"Montgomery","year":"2009","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejphar.2025.177317_bib38","first-page":"724","article-title":"CX691, as an AMPA receptor positive modulator, improves the learning and memory in a rat model of Alzheimer's disease","volume":"21","author":"Mozafari","year":"2018","journal-title":"Iran J Basic Med Sci"},{"key":"10.1016\/j.ejphar.2025.177317_bib39","doi-asserted-by":"crossref","first-page":"e999","DOI":"10.1038\/tp.2016.273","article-title":"Glutamatergic and GABAergic gene sets in attention-deficit\/hyperactivity disorder: association to overlapping traits in ADHD and autism","volume":"7","author":"Naaijen","year":"2017","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.ejphar.2025.177317_bib40","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/S0028-3908(01)00133-2","article-title":"Mechanism and impact of allosteric AMPA receptor modulation by the ampakine CX546","volume":"41","author":"Nagarajan","year":"2001","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2025.177317_bib41","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/clpt.2009.194","article-title":"Selective antagonism of opioid-induced ventilatory depression by an ampakine molecule in humans without loss of opioid analgesia","volume":"87","author":"Oertel","year":"2010","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2025.177317_bib42","doi-asserted-by":"crossref","first-page":"10912","DOI":"10.1523\/JNEUROSCI.1869-07.2007","article-title":"Brain-derived neurotrophic factor expression and respiratory function improve after ampakine treatment in a mouse model of Rett syndrome","volume":"27","author":"Ogier","year":"2007","journal-title":"J. Neurosci. : the official journal of the Society for Neuroscience"},{"key":"10.1016\/j.ejphar.2025.177317_bib43","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0169-328X(96)00280-X","article-title":"Comparison of the effects of an ampakine with those of methamphetamine on aggregate neuronal activity in cortex versus striatum","volume":"46","author":"Palmer","year":"1997","journal-title":"Brain Res Mol Brain Res"},{"key":"10.1016\/j.ejphar.2025.177317_bib44","doi-asserted-by":"crossref","first-page":"e299","DOI":"10.1371\/journal.pbio.0030299","article-title":"Facilitation of task performance and removal of the effects of sleep deprivation by an ampakine (CX717) in nonhuman primates","volume":"3","author":"Porrino","year":"2005","journal-title":"PLoS Biol."},{"key":"10.1016\/j.ejphar.2025.177317_bib45","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2024.1409401","article-title":"Fluorescence lifetime imaging of AMPA receptor endocytosis in living neurons: effects of Abeta and PP1","volume":"17","author":"Prinkey","year":"2024","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.ejphar.2025.177317_bib46","doi-asserted-by":"crossref","first-page":"173","DOI":"10.3390\/futurepharmacol4010012","article-title":"Low-impact ampakine CX1739 exerts pro-cognitive effects and reverses opiate-induced respiratory depression in rodents","volume":"4","author":"Radin","year":"2024","journal-title":"Future Pharmacology"},{"key":"10.1016\/j.ejphar.2025.177317_bib47","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.biopha.2018.06.008","article-title":"Effects of chronic systemic low-impact ampakine treatment on neurotrophin expression in rat brain","volume":"105","author":"Radin","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejphar.2025.177317_bib48","doi-asserted-by":"crossref","first-page":"494","DOI":"10.3390\/futurepharmacol4030028","article-title":"Preclinical pharmacology of the low-impact ampakine CX717","volume":"4","author":"Radin","year":"2024","journal-title":"Future Pharmacology"},{"key":"10.1016\/j.ejphar.2025.177317_bib49","doi-asserted-by":"crossref","first-page":"3467","DOI":"10.1089\/neu.2021.0301","article-title":"Ampakines stimulate diaphragm activity after spinal cord injury","volume":"38","author":"Rana","year":"2021","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.ejphar.2025.177317_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2024.114769","article-title":"Ampakines increase diaphragm activation following mid-cervical contusion injury in rats","volume":"376","author":"Rana","year":"2024","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.ejphar.2025.177317_bib51","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1097\/ALN.0b013e31819faa2a","article-title":"Ampakine CX717 protects against fentanyl-induced respiratory depression and lethal apnea in rats","volume":"110","author":"Ren","year":"2009","journal-title":"Anesthesiology"},{"key":"10.1016\/j.ejphar.2025.177317_bib52","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1152\/japplphysiol.00752.2012","article-title":"Respiratory depression in rats induced by alcohol and barbiturate and rescue by ampakine CX717","volume":"113","author":"Ren","year":"2012","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.ejphar.2025.177317_bib53","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1097\/ALN.0b013e318291079c","article-title":"Coadministration of the AMPAKINE CX717 with propofol reduces respiratory depression and fatal apneas","volume":"118","author":"Ren","year":"2013","journal-title":"Anesthesiology"},{"key":"10.1016\/j.ejphar.2025.177317_bib54","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202012433","article-title":"The enhancement of activity rescues the establishment of Mecp2 null neuronal phenotypes","volume":"13","author":"Scaramuzza","year":"2021","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.ejphar.2025.177317_bib55","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1124\/jpet.113.204735","article-title":"Positive allosteric modulation of AMPA receptors from efficacy to toxicity: the interspecies exposure-response continuum of the novel potentiator PF-4778574","volume":"347","author":"Shaffer","year":"2013","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejphar.2025.177317_bib56","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.nbd.2010.10.015","article-title":"Brief ampakine treatments slow the progression of Huntington's disease phenotypes in R6\/2 mice","volume":"41","author":"Simmons","year":"2011","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.ejphar.2025.177317_bib57","doi-asserted-by":"crossref","first-page":"4906","DOI":"10.1073\/pnas.0811228106","article-title":"Up-regulating BDNF with an ampakine rescues synaptic plasticity and memory in Huntington's disease knockin mice","volume":"106","author":"Simmons","year":"2009","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.ejphar.2025.177317_bib58","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/s41586-022-04556-w","article-title":"Rare coding variants in ten genes confer substantial risk for schizophrenia","volume":"604","author":"Singh","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2025.177317_bib59","doi-asserted-by":"crossref","DOI":"10.1038\/s41380-024-02473-0","article-title":"The glutamatergic system in Alzheimer's disease: a systematic review with meta-analysis","author":"Soares","year":"2024","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.ejphar.2025.177317_bib60","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.pbb.2019.06.004","article-title":"TAK-137, an AMPA receptor potentiator with little agonistic effect, produces antidepressant-like effect without causing psychotomimetic effects in rats","volume":"183","author":"Suzuki","year":"2019","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejphar.2025.177317_bib61","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1124\/pr.109.002451","article-title":"Glutamate receptor ion channels: structure, regulation, and function","volume":"62","author":"Traynelis","year":"2010","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ejphar.2025.177317_bib62","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.schres.2013.01.031","article-title":"Abnormal N-linked glycosylation of cortical AMPA receptor subunits in schizophrenia","volume":"146","author":"Tucholski","year":"2013","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.ejphar.2025.177317_bib63","doi-asserted-by":"crossref","first-page":"937","DOI":"10.3357\/ASEM.2055.2007","article-title":"Ampakine (CX717) effects on performance and alertness during simulated night shift work","volume":"78","author":"Wesensten","year":"2007","journal-title":"Aviat Space Environ. Med."},{"key":"10.1016\/j.ejphar.2025.177317_bib64","article-title":"AMPA receptors play an important role in the biological consequences of spinal cord injury: implications for AMPA receptor modulators for therapeutic benefit","volume":"116302","author":"Witkin","year":"2024","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejphar.2025.177317_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2020.113465","article-title":"Ampakines stimulate phrenic motor output after cervical spinal cord injury","volume":"334","author":"Wollman","year":"2020","journal-title":"Exp. Neurol."},{"issue":"23","key":"10.1016\/j.ejphar.2025.177317_bib72","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.1001\/jama.284.23.3043","article-title":"Ethical principles for medical research involving human subjects","volume":"284","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.ejphar.2025.177317_bib66","doi-asserted-by":"crossref","first-page":"488","DOI":"10.3390\/molecules21040488","article-title":"Design, synthesis and biological evaluation of brain-targeted thiamine disulfide prodrugs of ampakine compound LCX001","volume":"21","author":"Xiao","year":"2016","journal-title":"Molecules"},{"key":"10.1016\/j.ejphar.2025.177317_bib67","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.4155\/fmc-2020-0256","article-title":"The impact and mechanism of ampakine CX1739 on protection against respiratory depression in rats","volume":"12","author":"Xiao","year":"2020","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.ejphar.2025.177317_bib68","doi-asserted-by":"crossref","first-page":"e328","DOI":"10.1097\/j.pain.0000000000002291","article-title":"Prevalence of chronic pain among adults in the United States","volume":"163","author":"Yong","year":"2022","journal-title":"Pain"},{"key":"10.1016\/j.ejphar.2025.177317_bib69","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.schres.2020.03.037","article-title":"Functional impairment of cortical AMPA receptors in schizophrenia","volume":"249","author":"Zeppillo","year":"2022","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.ejphar.2025.177317_bib70","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/aps.2017.138","article-title":"Prefrontal AMPA receptors are involved in the effect of methylphenidate on response inhibition in rats","volume":"39","author":"Zhang","year":"2018","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.ejphar.2025.177317_bib71","doi-asserted-by":"crossref","first-page":"876","DOI":"10.2174\/156720511798192709","article-title":"Effects of the putative cognitive-enhancing ampakine, CX717, on attention and object recognition memory","volume":"8","author":"Zheng","year":"2011","journal-title":"Curr. Alzheimer Res."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299925000706?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299925000706?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T17:16:39Z","timestamp":1741367799000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299925000706"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":72,"alternative-id":["S0014299925000706"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2025.177317","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety, tolerability and pharmacokinetic profile of the low-impact ampakine CX717 in young healthy male subjects and elderly healthy male and female subjects","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2025.177317","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"177317"}}